AF
VSTM icon

Amalgamated Financial’s Verastem VSTM Stock Holding History

Amalgamated Financial’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$40K Buy
+2,346
New +$40.4K ﹤0.01% 2526

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Amalgamated Financial's VSTM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Verastem (VSTM) in Q1 2022: 2,346 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #2526 among its holdings.

140 funds tracked by Wall St. Rank hold VSTM as of Q1 2022.

  • Amalgamated Financial held 2,346 shares of Verastem worth $40K as of Q1 2022.
  • Verastem was a new Amalgamated Financial position in Q1 2022.
  • Verastem made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2526 holding.
  • 140 funds tracked by Wall St. Rank held Verastem as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.